Stock listing
OTC:ORXOY Orexo AB Stock
US listing (OTC) of Orexo AB · home listing Stockholm:ORX
Follow Orexo AB into a list and get an email when it puts out news.
Share price · OTC:ORXOY
$0.237 USD 0.000 (0.0%)
Close on Nov 6, 2026
- Day range
- $0.237 – $0.237 USDNov 6, 2026
- Volume
- 64 sharesNov 6, 2026
- Market cap
- $8.33M USDAt the close on Nov 6, 2026 · price × 35.13M shares outstanding
- 52-week range
- $0.237 – $3.000 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $279 USDMedian day 0 shares · 49 days with no trades · last 3 months, Aug 6, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:ORX · Home | 0.983 SEK | -0.023 (-2.3%) | 286,207 | 1.052 | 1.052 | 0.930 | 1.006 | Close on Nov 20, 2026 |
| OTC:ORXOF | $0.082 USD | -0.006 (-7.4%) | 5,000 | $0.082 | $0.082 | $0.082 | $0.088 | Close on Nov 17, 2026 |
| OTC:ORXOY | $0.237 USD | 0.000 (0.0%) | 64 | $0.237 | $0.237 | $0.237 | $0.237 | Close on Nov 6, 2026 |
| Frankfurt:C5G | €0.038 EUR | -0.003 (-8.3%) | — | €0.039 | €0.039 | €0.038 | €0.041 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · OTC:ORXOY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.237 | 0.000 | 0.0% | $0.237 | $0.237 | $0.237 | 64 | |
| $0.237 | -0.206 | -46.5% | $0.237 | $0.237 | $0.237 | 400 | |
| $0.443 | 0.000 | 0.0% | $0.443 | $0.443 | $0.443 | 0 | |
| $0.443 | -0.221 | -33.3% | $0.443 | $0.443 | $0.443 | 2,600 | |
| $0.664 | 0.000 | 0.0% | $0.664 | $0.664 | $0.664 | 0 | |
| $0.664 | 0.000 | 0.0% | $0.664 | $0.664 | $0.664 | 0 | |
| $0.664 | 0.000 | 0.0% | $0.664 | $0.664 | $0.664 | 0 | |
| $0.664 | 0.000 | 0.0% | $0.664 | $0.664 | $0.664 | 0 | |
| $0.664 | 0.000 | 0.0% | $0.664 | $0.664 | $0.664 | 0 | |
| $0.664 | 0.000 | 0.0% | $0.664 | $0.664 | $0.664 | 0 | |
| $0.664 | -0.086 | -11.5% | $0.492 | $0.664 | $0.492 | 200 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 0 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 0 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 0 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 0 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 0 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 0 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 8 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 0 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 0 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 0 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 0 | |
| $0.750 | +0.021 | +2.9% | $0.750 | $0.750 | $0.750 | 1,400 | |
| $0.729 | -0.371 | -33.7% | $0.825 | $0.825 | $0.729 | 1,900 | |
| $1.100 | 0.000 | 0.0% | $1.100 | $1.100 | $1.100 | 0 | |
| $1.100 | 0.000 | 0.0% | $1.100 | $1.100 | $1.100 | 0 | |
| $1.100 | 0.000 | 0.0% | $1.100 | $1.100 | $1.100 | 0 | |
| $1.100 | 0.000 | 0.0% | $1.100 | $1.100 | $1.100 | 0 | |
| $1.100 | 0.000 | 0.0% | $1.100 | $1.100 | $1.100 | 0 | |
| $1.100 | 0.000 | 0.0% | $1.100 | $1.100 | $1.100 | 0 | |
| $1.100 | 0.000 | 0.0% | $1.100 | $1.100 | $1.100 | 0 | |
| $1.100 | 0.000 | 0.0% | $1.100 | $1.100 | $1.100 | 0 | |
| $1.100 | -0.290 | -20.9% | $1.255 | $1.255 | $1.100 | 3,400 | |
| $1.390 | 0.000 | 0.0% | $1.390 | $1.390 | $1.390 | 100 | |
| $1.390 | 0.000 | 0.0% | $1.390 | $1.390 | $1.390 | 0 | |
| $1.390 | 0.000 | 0.0% | $1.390 | $1.390 | $1.390 | 0 | |
| $1.390 | 0.000 | 0.0% | $1.390 | $1.390 | $1.390 | 100 | |
| $1.390 | 0.000 | 0.0% | $1.390 | $1.390 | $1.390 | 100 | |
| $1.390 | 0.000 | 0.0% | $1.390 | $1.390 | $1.390 | 0 | |
| $1.390 | 0.000 | 0.0% | $1.390 | $1.390 | $1.390 | 0 | |
| $1.390 | 0.000 | 0.0% | $1.390 | $1.390 | $1.390 | 0 | |
| $1.390 | 0.000 | 0.0% | $1.390 | $1.390 | $1.390 | 0 | |
| $1.390 | 0.000 | 0.0% | $1.390 | $1.390 | $1.390 | 0 | |
| $1.390 | -0.380 | -21.5% | $1.390 | $1.390 | $1.390 | 7,000 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 1 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 1 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 1 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 4 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 400 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 | |
| $1.770 | 0.000 | 0.0% | $1.770 | $1.770 | $1.770 | 0 |
- Ticker
- OTC:ORXOY
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 11, 2026
Orexo publishes disclosure document regarding rights issue
Latest earnings call · Oct 22, 2026
Orexo (Stockholm:ORX) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 22, 2026
Q3 2026 Earnings Presentation
Earnings · 21 slides
Calls
Replays
Orexo (Stockholm:ORX) Q3 2026 Earnings Call
Thu, Oct 22, 2026 · 8:00 AM ET
Watch TranscriptOrexo (Stockholm:ORX) Q2 2026 Earnings Call
Thu, Jul 16, 2026 · 8:00 AM ET
Watch TranscriptOrexo (Stockholm:ORX) Q1 2026 Earnings Call
Tue, Apr 28, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Orexo: ORXOY - Books will close at the close of business, November 5, 2026.
Nov 5, 2026
Closed $0.237 (-46.5%) on Nov 5, 2026
Orexo reports encouraging bioavailability in first in vivo study of oral semaglutide formulation based on AmorphOX
Oct 14, 2026
Closed $0.75 (0.0%) on Oct 14, 2026
Orexo reaches non-binding agreement in principle to settle investigation by US Department of Justice
Aug 31, 2026
Closed $1.77 (0.0%) on Sep 1, 2026
Orexo appoints Raheleh Nassaji as SVP Business Development, strengthening its focus on new partnerships
Jun 9, 2026
Closed $1.80 (-12.0%) on Jun 9, 2026
Orexo announces positive outcome from an in-vivo study of OX390
May 19, 2026
Closed $2.05 (0.0%) on May 19, 2026
Earnings Call Q1 2026 (engelska)
Apr 28, 2026
Closed $2.65 (0.0%) on Apr 28, 2026
Earnings Call Q1 2026
Apr 28, 2026
Closed $2.65 (0.0%) on Apr 28, 2026
Q1 2026 Interim Report MASTER
Apr 28, 2026
Closed $2.65 (0.0%) on Apr 28, 2026
Q1 2026 Interim Report 2026
Apr 28, 2026
Closed $2.65 (0.0%) on Apr 28, 2026
Decks
Q3 2026 Earnings Presentation
Earnings · 21 slides · Oct 22, 2026
DNB Carnegie Small Cap Day 2026
Conference · 15 slides · Aug 31, 2026
Q2 2026 Earnings Presentation
Earnings · 18 slides · Jul 16, 2026
ABGSC Investor Day 2026
Conference · 14 slides · May 22, 2026
Orexo AB on 6ix
- News releases
- 18 in the last 12 months · 21 in all · newest Nov 11, 2026 · oldest 2025
- Calls
- 11 calls with a replay · 11 with a transcript · latest Oct 22, 2026
- Decks
- 55 decks · latest Oct 22, 2026
Where Orexo AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:ORX · Home listing | Stockholm | Sweden | SEK |
| LS Exchange:A0HG6G | LS Exchange | Germany | EUR |
| LSIN:0H19 | LSIN | United Kingdom | SEK |
| Lang & Schwarz:A0HG6G | Lang & Schwarz | Germany | EUR |
| OTC:ORXOF | OTC | United States | USD |
| OTC:ORXOY · This page | OTC | United States | USD |
| Aquis:ORXS | Aquis | United Kingdom | SEK |
| Aquis:ORXS | Aquis | United Kingdom | SEK |
| Frankfurt:C5G | Frankfurt | Germany | EUR |
| Stuttgart:C5G | Stuttgart | Germany | EUR |
| Turquoise:ORXS | Turquoise | United Kingdom | SEK |
Log in to ask 6ix AI your own questions about Orexo AB.